Abstract

Human history is observing a very strange time fighting an invisible enemy, the novel COVID-19 coronavirus. initially observed in the Wuhan province of China, now vastly spreading around the world. The Pandemic which COVID-19 has made on the Globe needs no depiction. The virus has been accounted for to be affecting the lungs and related respiratory tracts promoting harm of the alveoli. It has been accounted the respiratory sickness is the prevailing Clinical indication of COVID-19. This review article discussed for an easily understanding of the causes, different type of Human viruses regarded of Coronavirus, clinical diagnosis of RT-PCR, Primary prevention and control of the virus. Therefore, this review article main theme is focusing on more research work to be carried out to provide more reliable and valid effect to control and mange public emergency in both acute and chronic conditions of coronavirus.

Keywords: COVID-19; Pandemic; RT-PCR; Prevention; Respiratory

References

1. Lu R., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origin and receptor binding”. Lancet 10224 (2020): 565-574.
2. “Coronavirus disease (COVID-19) situation reports” (2020).
3. Riou J and Althaus CL. “Pattern of early human- to- human transmission of a Wuhan 2019 coronavirus (2019-ncoV), December 2019 to January 2020”. Eurosurveillance4 (2020): 2000058.
4. Liu Y., et al. “The reproductive number of COVID-19 is higher compared to SARS coronavirus”. Journal of Travel Medicine (2020).
5. "2019 Novel coronavirus (2019-ncoV)". Centres for Disease control and prevention (2020).
6. Geller C., et al. “Human coronavirus: insights into environmental resistance and its influence on the development of new antiseptic strategies". Viruses11 (2012): 3044-3068.
7. Michael J Loeffelholz and Yi-wei Tang. “Laboratory diagnosis of emerging human coronavirus infections- the state of the art”.
8. Shereen MA., et al. “COVID-19 Infection: origin, Transmission and characteristics of Human Coronavirus”. Jade Women Red Flats 24 (2020): 91-98.
9. Maier HJ and Bickeprevention Britton P. “Coronavirus: methods and protocols, coronavirus method protective” (2015): 1-282.
10. https://www.BBC.com/future/article/20200317-covid-19-how-long-does-the-coronavirus-last-on-surface
11. , et al. “A review of COVID-19 (coronavirus disease-2019) diagnosis, treatment and prevention” 4.2 (2020): 116-125.
12. Signal T. “A Review of coronavirus diseases-2019 (COVID-19)”. Indian Journal of Pediatrics 4 (2020): 281-286.
13. https://www.IAEA.org/newscenter/news/how-is-the-covid-19-virus-detected-using-real-time-rt-pcr
14. , et al. “COVID-19: An overview”. WJPR 9 (2020): 1810-1827.
15. Maharshi Malakar." Coronavirus- A review article”. Acts Scientific Dental Sciences5 (2020): 10-12.
16. Jiancheng Z., et al. “Current status of Potential therapeutic candidates for the COVID-19 Crisis”. Brain, Behavior, and Immunity 87 (2020): 59-73.
17. Yung F T., et al. “A Review of SARS- CoV-2 and the ongoing Trails”. International Journal of Molecular Sciences 21 (2020): 2657.
18. Dayal D and Gupta S. “Connecting BCG vaccination and COVID-19: Additional Data”. Med Rxiv (2020).
19. https://www.theHindu.com/Sci-tech/Science/inactivated-prcovacc-vaccine-found-safe-efficacious-in-animal-study/article 2
20. , et al. “Coronavirus (COVID-19): Clinical features, diagnosis and treatment 9.5 (2020).
21. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 49740.
22. W Guan., et al. “Clinical characteristics of Coronavirus Diseases 2019 in China”.
23. Richman DD., et al. “Clinical virology, 4^th edition”. Washington: ASM Press (2016).
24. Garner JS., et al. “CDC definitions of nosocomial infections”. American Journal of Infection Control 16 (1988): 128-140.

Citation

Citation: V Anilkumar. “A Minireview on Pandemic Novel COVID-19".Acta Scientific Pharmaceutical Sciences 4.7 (2020): 19-24.

Copyright

Copyright: © 2020 V Anilkumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.